



Accelrys: Accelrys Announces Support for Microsoft Office SharePoint Server Platform to Expand Reach
SAN DIEGO, CA--(Marketwire - March 23, 2009) - Accelrys, Inc. (
"As one of the fastest growing products in Microsoft's history, SharePoint Server is currently used by many of the top pharmaceutical and chemical companies as a collaboration and content management tool," said Accelrys' Chief Science Officer Frank Brown, PhD. "We are excited to announce the integration of our Pipeline Pilot Enterprise Server with SharePoint Server. Our embedded solution will fill the gap for SharePoint Server users in the scientific community by providing customers with the means to access and use large amounts of scientific data to gain insight and make informed decisions in the areas of discovery and development."
"Life science companies today are facing major challenges in the areas of research, discovery and development, particularly with the sheer volume of data and an inability to collaborate and share information effectively among teams," said Dr. Rudy Potenzone, worldwide life sciences industry technology strategist, Microsoft Corp. "Accelrys' cutting-edge technology will empower customers who already utilize Microsoft Office SharePoint Server with advanced, highly vertical tools that enable scientific collaboration and ultimately help them make better business decisions."
The Microsoft Office SharePoint Server integration will allow Accelrys applications to be executed and displayed from the familiar, widely supported and easy-to-use SharePoint Server environment through Pipeline Enterprise Server, the Accelrys scientific business intelligence platform.
Dr. Potenzone, who also serves as the Director of the BioIT Alliance, added, "This product advancement by Accelrys, one of the founding members of the BioIT Alliance, demonstrates two of the goals of the Alliance: encouraging novel technologies for use by the Members; and fostering collaboration between them. SharePoint will serve as a key integration point between these Accelrys tools and products of other Alliance members in the future."
For more information about Accelrys products and solutions, please visit [ http://accelrys.com/ ].
About Accelrys, Inc.
Headquartered in San Diego, California, Accelrys [ develops scientific business intelligence ] software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products [ industries ]. Our [ customers ] include many Fortune 500 companies and other commercial entities, as well as academic and government entities. We have a vast portfolio of computer-aided design modeling and simulation offerings which assist our customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Our [ scientific business intelligence platform ] underlies most of our computer-aided design modeling and simulation offerings. Our platform can be used with our products, our competitors' products and our customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable our customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit its website at [ http://accelrys.com/ ]
About the BioIT Alliance
Formed in 2006, the BioIT Alliance is a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine. Founding members include Accelrys Software Inc., Affymetrix, Inc., Agilent Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation, Geospiza Inc., Hewlett-Packard Development Company, L.P., Illumina Inc., InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at [ http://www.bioitalliance.org ].
Forward-Looking Statements
This press release contains forward-looking statements. Such statements, including statements relating to the potential benefits of the collaboration between Microsoft and Accelrys, benefits to the companies and their customers, and the benefits resulting from the integration of our scientific operating platform with SharePoint are subject to risks and uncertainties including, but not limited to, the risks that the collaboration will not result in benefits or additional sales, and that the companies' products will not be timely or successfully completed, developed or achieve market acceptance, demand relating to these products, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys and Microsoft disclaim any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in their expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.